Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor B Talisa

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
JAMA|January 24, 2017
Proportion and Cost of Unplanned 30-Day Readmissions After Sepsis Compared With Other Medical ConditionsFlorian B Mayr, Victor B Talisa, Vikram Balakumar, et al.
Journal of Intensive Care Medicine|November 26, 2025
Racial and Ethnic Inequalities Among Survivors of Critical Illness in the MIMIC-IV DatabaseHiam Naiditch, Victor B Talisa, Jared W Magnani, et al.
BMJ Open|November 25, 2025
Identifying racial inequalities in long-term outcomes among survivors of critical illness with sepsis in a US cohort: a retrospective cohort studyHiam Naiditch, Victor B Talisa, Jared W Magnani, et al.
Open Forum Infectious Diseases|July 26, 2022
Comparative COVID-19 Vaccine Effectiveness Over Time in VeteransFlorian B Mayr, Victor B Talisa, Obaid S Shaikh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 2022
Vaccine Effectiveness of 3 Versus 2 Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccines in a High-Risk National PopulationAdeel A Butt, Victor B Talisa, Peng Yan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 9, 2022
Real-World Effectiveness of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccines in Preventing Confirmed Infection in Patients on Chronic HemodialysisAdeel A Butt, Victor B Talisa, Peng Yan, et al.
Surgical Infections|August 25, 2020
Estimating the Impact of Necrotizing Soft Tissue Infections in the United States: Incidence and Re-AdmissionsAddison K May, Victor B Talisa, David A Wilfret, et al.
The Journal of Infectious Diseases|September 15, 2023
Nirmatrelvir/Ritonavir Use and Hospitalizations or Death in a Previously Uninfected Nonhospitalized High-Risk Population With COVID-19: A Matched Cohort StudyAdeel A Butt, Peng Yan, Obaid S Shaikh, et al.
The Journal of Infectious Diseases|June 1, 2023
Molnupiravir Use and 30-Day Hospitalizations or Death in a Previously Uninfected Nonhospitalized High-risk Population With COVID-19Adeel A Butt, Peng Yan, Obaid S Shaikh, et al.
Scientific Reports|July 3, 2025
Preoperative renal functional reserve as a predictor of acute kidney injury in young adults with congenital heart diseaseDana Y Fuhrman, George J Schwartz, David S Cooper, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
JAMA|January 24, 2017
Proportion and Cost of Unplanned 30-Day Readmissions After Sepsis Compared With Other Medical ConditionsFlorian B Mayr, Victor B Talisa, Vikram Balakumar, et al.
Journal of Intensive Care Medicine|November 26, 2025
Racial and Ethnic Inequalities Among Survivors of Critical Illness in the MIMIC-IV DatabaseHiam Naiditch, Victor B Talisa, Jared W Magnani, et al.
BMJ Open|November 25, 2025
Identifying racial inequalities in long-term outcomes among survivors of critical illness with sepsis in a US cohort: a retrospective cohort studyHiam Naiditch, Victor B Talisa, Jared W Magnani, et al.
Open Forum Infectious Diseases|July 26, 2022
Comparative COVID-19 Vaccine Effectiveness Over Time in VeteransFlorian B Mayr, Victor B Talisa, Obaid S Shaikh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 2022
Vaccine Effectiveness of 3 Versus 2 Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccines in a High-Risk National PopulationAdeel A Butt, Victor B Talisa, Peng Yan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 9, 2022
Real-World Effectiveness of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccines in Preventing Confirmed Infection in Patients on Chronic HemodialysisAdeel A Butt, Victor B Talisa, Peng Yan, et al.
Surgical Infections|August 25, 2020
Estimating the Impact of Necrotizing Soft Tissue Infections in the United States: Incidence and Re-AdmissionsAddison K May, Victor B Talisa, David A Wilfret, et al.
The Journal of Infectious Diseases|September 15, 2023
Nirmatrelvir/Ritonavir Use and Hospitalizations or Death in a Previously Uninfected Nonhospitalized High-Risk Population With COVID-19: A Matched Cohort StudyAdeel A Butt, Peng Yan, Obaid S Shaikh, et al.
The Journal of Infectious Diseases|June 1, 2023
Molnupiravir Use and 30-Day Hospitalizations or Death in a Previously Uninfected Nonhospitalized High-risk Population With COVID-19Adeel A Butt, Peng Yan, Obaid S Shaikh, et al.
Scientific Reports|July 3, 2025
Preoperative renal functional reserve as a predictor of acute kidney injury in young adults with congenital heart diseaseDana Y Fuhrman, George J Schwartz, David S Cooper, et al.
Pageof 4